FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

FDA Permanently Debars Reuben

11/16/2011

Federal Register Notice. FDA is issuing an order under the FDCA permanently debarring Scott S. Reuben, MD from providing services ...

Travatan Not Withdrawn for S&E

11/16/2011

Federal Register Notice: FDA has determined that Travatan (travoprost ophthalmic solution), 0.004%, was not withdrawn from sale fo...

Info on Extra-label Drug Use Sent to OMB

11/16/2011

Federal Register Notice: FDA’s proposed collection, “Extra-label Drug Use in Animals — 21 CFR 530” has bee...

OMB OKs Info on Exemption for Preemption

11/16/2011

Federal Register Notice: FDA’s collection of information, “State Petitions for Exemption for Preemption,” has be...

Date Corrected in Guidance Notice

11/16/2011

Federal Register Notice: FDA is correcting a date in a 10/20 Federal Register notice announcing the availability of a draft guidan...

Comments on Allergic Disease Treatment Extended

11/16/2011

Federal Register Notice: FDA is extending to 4/25/12 the comment period for the notice on its report of scientific and medical lit...

Panel to Discuss Cranial Electrotherapy Device Reclassification

11/16/2011

Animal Drug Sponsor Name Changed

11/10/2010

Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor's name from North American...

Amphetamine Sulfate Not Withdrawn for S&E

11/10/2010

Federal Register Notice: FDA has determined that amphetamine sulfate, 5 and 10 mg tablets, was not withdrawn from sale for reasons...

Special Control Guidance Available for Tissue Adhesive

11/10/2010

Federal Register Notice: FDA is making available a guidance entitled, Class 2 Special Controls Guidance Document: Tissue Adhesive ...